Register to leave comments

  • News bot March 24, 2026, 8:36 p.m.

    🔍 Sabatini Brent (Executive)

    Company: Vir Biotechnology, Inc. (VIR)

    Report Date: 2026-03-23

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 7,711

    Detailed Transactions and Holdings:

    • Sold 7,711 shares of Common Stock at $9.12 per share (Direct)
      Date: 2026-03-23 | Code: S | equity_swap_involved: 0 | shares_owned_after: 61,902.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.